Sweden Archives

News and Trends 16 Feb 2023

Genetic study reveals high variation in T-cell receptor genes

T-cells are central in the protection against infections and cancer. With the help of TCRs (T-cell receptors), cells recognize foreign invaders and tumor cells. “It was previously unknown how variable…

February 16, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 7 Feb 2023

Antibody candidate for treating serious liver disease

There is currently no drug for treating non-alcoholic fatty liver disease, which affects many people with type 2 diabetes and which can result in other serious liver diseases. However, a…

February 7, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 31 Jan 2023

Active Biotech trial confirms eye treatment safety

Active Biotech has announced the completion of the phase I clinical study testing the safety and tolerability of its newly-developed laquinimod eye drop formulation in healthy subjects. According to the…

January 31, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 27 Jan 2023

EMA accepts Marketing Authorization Application for lecanemab to treat early Alzheimer’s disease

BioArctic AB's partner Eisai says the European Medicines Agency (EMA) has accepted a marketing authorization application (MAA) for lecanemab. Lecanemab, known as LEQEMBI in the U.S., is an investigational anti-amyloid…

January 27, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 27 Jan 2023

Psoriasis drug may help treat type 1 diabetes

A large clinical study is now beginning on an approved drug for treating psoriasis. The drug will be tested on patients who were recently diagnosed with type 1 diabetes. The…

January 27, 2023 - 5 minutesmins - By Jim Cornall

News and Trends 26 Jan 2023

New tool to fight antibiotic resistance

The World Health Organization (WHO) ranks antibiotic resistance as one of the top 10 threats to global health. In response, researchers at Chalmers University of Technology in Sweden have developed…

January 26, 2023 - 5 minutesmins - By Jim Cornall

How clinical trials benefit from decentralized solutions: A Nordic case study

Digitization is changing the way clinical trials are conducted. Spurred by the pandemic, decentralized clinical trials are on the rise, with clear benefits for clinicians and patients. Three Nordic companies…

January 26, 2023 - 6 minutesmins - By Ute Boronowsky

News and Trends 26 Jan 2023

First patient treated in Atrogi type 2 diabetes clinical study

Atrogi AB, an early-stage Swedish pharma company, has announced that the first patient has been enrolled in a phase 1a/b study. Atrogi’s drug candidate, ATR-258 is a first in class…

January 26, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 18 Jan 2023

BioInvent receives funding for blood cancer treatments

BioInvent International AB has been selected as partner of The Leukemia & Lymphoma Society’s Therapy Acceleration Program (LLS TAP). The program is aimed at advancing the company’s program to treat…

January 18, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 23 Dec 2022

Watch: Something to SmiLe about in southern Sweden

SmiLe Incubator is a life science business incubator based in Medicon Village in Lund, Sweden. SmiLe helps entrepreneurs commercialize their ideas. There are currently 30 companies in the SmiLe Incubator…

December 23, 2022 - 1 minutemin - By Jim Cornall

News and Trends 23 Dec 2022

Watch: The Medicon Valley Alliance celebrates 25th anniversary

The Medicon Valley Alliance (MVA) is a non-profit membership organization in the Danish-Swedish life science cluster Medicon Valley. It covers eastern Denmark, which includes the capital, Copenhagen, as well as…

December 23, 2022 - 1 minutemin - By Jim Cornall

News and Trends 23 Dec 2022

Affibody signs €20 million loan agreement

Affibody Medical AB has received a €20 million ($21.2 million) venture debt loan facility from the European Investment Bank, EIB, backed by the InvestEU program. The investment will support Affibody’s…

December 23, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 21 Dec 2022

Anocca secures €25M to develop next-generation T-cell therapies for cancer

Anocca, a fully integrated cell therapy biotechnology company, has secured €25 million ($26.5 million) venture debt financing from the European Investment Bank (EIB). Anocca’s CEO and co-founder Reagan Jarvis said:…

December 21, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 20 Dec 2022

Watch: SwedenBIO leading the way

SwedenBIO is the national non-profit association for the life science industry in Sweden, with more than 300 members.

December 20, 2022 - 1 minutemin - By Jim Cornall

News and Trends 20 Dec 2022

Watch: Sigrid CEO talks about lifestyle diseases

Sigrid Therapeutics AB was founded in 2014 by Tore Bengtsson and Sana Alajmovic, with the vision of transforming the way modern day chronic lifestyle diseases are treated and prevented. The…

December 20, 2022 - 1 minutemin - By Jim Cornall

News and Trends 20 Dec 2022

Watch: Mendus interview

Mendus AB is a Swedish company dedicated to changing the course of cancer treatment by addressing tumor recurrence and improving survival outcomes for cancer patients, while preserving quality of life. …

December 20, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 19 Dec 2022

Watch: InfraLife supports Sweden’s life sciences industry

InfraLife (Infra Access for Life Science Sweden) is a Swedish initiative to maximize the benefits of Sweden’s large scale research infrastructures SciLifeLab, MAX IV and ESS. Funded by Swedish Research…

December 19, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 19 Dec 2022

Watch: Pharm Assist at NLS Days

Pharm Assist is a consultancy company in Sweden offering regulatory affairs services for pharmaceutical and medical device companies. Founded in 1996, Pharm Assist employs more than 20 experts and has…

December 19, 2022 - 1 minutemin - By Jim Cornall

News and Trends 16 Dec 2022

Swedish research center expanding to take on antimicrobial resistance

Research on antibiotic resistance will get a boost when the Center for Antibiotic Resistance Research (CARe) in Gothenburg, Sweden, expands. Bacterial resistance to antibiotics is one of the most serious…

December 16, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 13 Dec 2022

Watch: Interview with Medicon Village CEO Petter Hartman

Medicon Village, in Lund, southern Sweden, is part of a cluster of life science research and development, together with actors such as the European Spallation Source (ESS), the BioMedical Centre…

December 13, 2022 - 2 minutesmins - By Jim Cornall

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Register for the Webinar

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Register for the Webinar

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering

Outsourcing in life science R&D today

Changing the Partner Discovery Game with Connect for Biotech

Looking to expand your network?

Subscribe to our newsletter to get the latest biotech news!